<DOC>
	<DOC>NCT00876421</DOC>
	<brief_summary>The objective of this study is to investigate efficacy, safety and tolerability of ONO-8539 in patients with overactive bladder.</brief_summary>
	<brief_title>Study of ONO-8539 in Patients With Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Patients with medical history of Overactive Bladder symptoms for &gt; 6 months Patients who have a history or presence of other significant diseases, which in the opinion of the investigator, might compromise the patient's safety or the evaluation of the study results</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>ONO-8539</keyword>
	<keyword>Overactive bladder</keyword>
	<keyword>OAB</keyword>
</DOC>